Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek®2: which mechanism involved and consequences in case of fluoroquinolone treatment?
European Journal of Clinical Microbiology & Infectious Diseases · 2025
DOI: 10.1007/s10096-024-05006-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2025. Verfasst von Manon Robert und 5 weiteren Autor:innen. Beteiligte Einrichtung: Service de Bactériologie et des Contrôles Microbiologiques, CHU Nantes, Nantes, France. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Levofloxacin, Anti-Bacterial Agents, Ciprofloxacin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Service de Bactériologie et des Contrôles Microbiologiques, CHU Nantes, Nantes, France.
- INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes Université, Nantes, France.
- Service des Maladies Infectieuses, Hôtel-Dieu, Centre Hospitalier Universitaire, Nantes, France.
- Centre d'Investigation Clinique Unité d'Investigation Clinique, Centre Hospitalier Universitaire, Nantes, France.
- Service de Bactériologie et des Contrôles Microbiologiques, CHU Nantes, Nantes, France. stephane.corvec@chu-nantes.fr.
- INSERM, Immunology and New Concepts in ImmunoTherapy, INCIT, UMR 1302, Nantes Université, Nantes, France. stephane.corvec@chu-nantes.fr.
Zitieren
APA
Robert, M., Ruffier d'Epenoux, L., Paquin, A., Boutoille, D., Guillouzouic, A., & Corvec, S. (2025). Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek®2: which mechanism involved and consequences in case of fluoroquinolone treatment?. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-024-05006-3
Vancouver
Robert M, Ruffier d'Epenoux L, Paquin A, Boutoille D, Guillouzouic A, Corvec S. Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek®2: which mechanism involved and consequences in case of fluoroquinolone treatment?. European Journal of Clinical Microbiology & Infectious Diseases. 2025. doi:10.1007/s10096-024-05006-3
BibTeX
@article{Robert2025,
author = {Robert, Manon and Ruffier d'Epenoux, Louise and Paquin, Axelle and Boutoille, David and Guillouzouic, Aurélie and Corvec, Stéphane},
title = {Ciprofloxacin-susceptible but levofloxacin-resistant Pseudomonas aeruginosa clinical strains with Vitek®2: which mechanism involved and consequences in case of fluoroquinolone treatment?},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2025},
doi = {10.1007/s10096-024-05006-3}
}
EUVIMED